NexgenRx Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was CAD 2.86 million compared to CAD 2.65 million a year ago. Net income was CAD 0.429581 million compared to CAD 0.509843 million a year ago. Basic earnings per share from continuing operations was CAD 0.006 compared to CAD 0.007 a year ago. Diluted earnings per share from continuing operations was CAD 0.006 compared to CAD 0.007 a year ago. For the nine months, revenue was CAD 8.43 million compared to CAD 7.93 million a year ago. Net income was CAD 1.17 million compared to CAD 1.27 million a year ago. Basic earnings per share from continuing operations was CAD 0.017 compared to CAD 0.018 a year ago. Diluted earnings per share from continuing operations was CAD 0.016 compared to CAD 0.018 a year ago.